{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T21:42:52Z","timestamp":1790026972774,"version":"4.0.1"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,11,29]],"date-time":"2018-11-29T00:00:00Z","timestamp":1543449600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007637","name":"colciencias","doi-asserted-by":"crossref","award":["111377757104"],"award-info":[{"award-number":["111377757104"]}],"id":[{"id":"10.13039\/100007637","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Genomics"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12864-018-5223-7","type":"journal-article","created":{"date-parts":[[2018,11,29]],"date-time":"2018-11-29T15:10:34Z","timestamp":1543504234000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Protein targets of thiazolidinone derivatives in Toxoplasma gondii and insights into their binding to ROP18"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8777-5359","authenticated-orcid":false,"given":"Diego","family":"Molina","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo","family":"Cossio-P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristian","family":"Rocha-Roa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina","family":"Pedraza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edwar","family":"Cortes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge E.","family":"G\u00f3mez-Mar\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,11,29]]},"reference":[{"key":"5223_CR1","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/B978-0-444-53490-3.00008-X","volume":"114","author":"SK Halonen","year":"2013","unstructured":"Halonen SK, Weiss LM. Toxoplasmosis. Handb Clin Neurol. 2013;114:125\u201345.","journal-title":"Handb Clin Neurol"},{"issue":"11","key":"5223_CR2","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1001\/archgenpsychiatry.2012.668","volume":"69","author":"MG Pedersen","year":"2012","unstructured":"Pedersen MG, Mortensen PB, Norgaard-Pedersen B, Postolache TT. Toxoplasma gondii infection and self-directed violence in mothers. Arch Gen Psychiatry. 2012;69(11):1123\u201330.","journal-title":"Arch Gen Psychiatry"},{"issue":"2","key":"5223_CR3","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.ijpara.2012.09.012","volume":"43","author":"DE Hill","year":"2013","unstructured":"Hill DE, Dubey JP. Toxoplasma gondii prevalence in farm animals in the United States. Int J Parasitol. 2013;43(2):107\u201313. https:\/\/doi.org\/10.1016\/j.ijpara.2012.09.012 .","journal-title":"Int J Parasitol"},{"issue":"1","key":"5223_CR4","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/S0002-9394(02)01537-4","volume":"134","author":"LH Bosch-Driessen","year":"2002","unstructured":"Bosch-Driessen LH, Verbraak FD, Suttorp-Schulten MSA, Van Ruyven RLJ, Klok AM, Hoyng CB, et al. A prospective, randomized trial of pyrimethamine and azithromycin vs pyrimethamine and sulfadiazine for the treatment of ocular toxoplasmosis. Am J Ophthalmol. 2002;134(1):34\u201340.","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"5223_CR5","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/S0002-9394(02)01527-1","volume":"134","author":"C Silveira","year":"2002","unstructured":"Silveira C, Belfort R, Muccioli C, Holland GN, Victora CG, Horta BL, et al. The effect of long-term intermittent trimethoprim\/sulfamethoxazole treatment on recurrences of toxoplasmic retinochoroiditis. Am J Ophthalmol. 2002;134(1):41\u20136.","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"5223_CR6","doi-asserted-by":"publisher","first-page":"140","DOI":"10.7150\/ijms.6.140","volume":"6","author":"Y Guex-Crosier","year":"2009","unstructured":"Guex-Crosier Y. Update on the treatment of ocular toxoplasmosis. Int J Med Sci. 2009;6(3):140\u20132.","journal-title":"Int J Med Sci"},{"key":"5223_CR7","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.ejmech.2013.11.017","volume":"72","author":"AC Tripathi","year":"2014","unstructured":"Tripathi AC, Gupta SJ, Fatima GN, Sonar PK, Verma A, Saraf SK. 4-Thiazolidinones: The advances continue. Eur J Med Chem. 2014;72:52\u201377. https:\/\/doi.org\/10.1016\/j.ejmech.2013.11.017 .","journal-title":"Eur J Med Chem"},{"issue":"10","key":"5223_CR8","doi-asserted-by":"publisher","first-page":"2575","DOI":"10.1016\/j.bmcl.2005.03.048","volume":"15","author":"RP Ten\u00f3rio","year":"2005","unstructured":"Ten\u00f3rio RP, Carvalho CS, Pessanha CS, De Lima JG, De Faria AR, Alves AJ, et al. Synthesis of thiosemicarbazone and 4-thiazolidinone derivatives and their in vitro anti-toxoplasma gondii activity. Bioorganic Med Chem Lett. 2005;15(10):2575\u20138.","journal-title":"Bioorganic Med Chem Lett"},{"issue":"1","key":"5223_CR9","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.bmc.2007.09.025","volume":"16","author":"TM de Aquino","year":"2008","unstructured":"de Aquino TM, Liesen AP, da Silva REA, Lima VT, Carvalho CS, de Faria AR, et al. Synthesis, anti-toxoplasma gondii and antimicrobial activities of benzaldehyde 4-phenyl-3-thiosemicarbazones and 2-[(phenylmethylene)hydrazono]-4-oxo-3-phenyl-5-thiazolidineacetic acids. Bioorganic Med Chem. 2008;16(1):446\u201356.","journal-title":"Bioorganic Med Chem"},{"issue":"2","key":"5223_CR10","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1590\/S0100-879X2009005000038","volume":"43","author":"CS Carvalho","year":"2010","unstructured":"Carvalho CS, De Melo EJT, Ten\u00f3rio RP, G\u00f3es AJS. Anti-parasitic action and elimination of intracellular toxoplasma gondii in the presence of novel thiosemicarbazone and its 4-thiazolidinone derivatives. Brazilian J Med Biol Res. 2010;43(2):139\u201349.","journal-title":"Brazilian J Med Biol Res"},{"issue":"9","key":"5223_CR11","doi-asserted-by":"publisher","first-page":"3685","DOI":"10.1016\/j.ejmech.2010.05.017","volume":"45","author":"AP Liesen","year":"2010","unstructured":"Liesen AP, De Aquino TM, Carvalho CS, Lima VT, De Ara\u00fajo JM, De Lima JG, et al. Synthesis and evaluation of anti-toxoplasma gondii and antimicrobial activities of thiosemicarbazides, 4-thiazolidinones and 1,3,4-thiadiazoles. Eur J Med Chem. 2010;45(9):3685\u201391. https:\/\/doi.org\/10.1016\/j.ejmech.2010.05.017 .","journal-title":"Eur J Med Chem"},{"key":"5223_CR12","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.ejmech.2014.08.046","volume":"86","author":"M D\u2019Ascenzio","year":"2014","unstructured":"D\u2019Ascenzio M, Bizzarri B, De Monte C, Carradori S, Bolasco A, Secci D, et al. Design, synthesis and biological characterization of thiazolidin-4-one derivatives as promising inhibitors of toxoplasma gondii. Eur J Med Chem. 2014;86:17\u201330.","journal-title":"Eur J Med Chem"},{"issue":"1","key":"5223_CR13","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1080\/14756366.2017.1316494","volume":"32","author":"S Carradori","year":"2017","unstructured":"Carradori S, Secci D, Bizzarri B, Chimenti P, De Monte C, Guglielmi P, et al. Synthesis and biological evaluation of anti-toxoplasma gondii activity of a novel scaffold of thiazolidinone derivatives. J Enzyme Inhib Med Chem. 2017;32(1):746\u201358.","journal-title":"J Enzyme Inhib Med Chem"},{"key":"5223_CR14","unstructured":"Frisch M, Trucks G, Schlegel H, Scuseria G, Robb M, Cheeseman J, et al. Gaussian 09, Revision C.01. Gaussian, Inc: Wallingford; 2009 34. p. 2009."},{"issue":"4","key":"5223_CR15","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1002\/(SICI)1096-987X(199803)19:4<404::AID-JCC3>3.0.CO;2-W","volume":"19","author":"V Barone","year":"1998","unstructured":"Barone V, Cossi M, Tomasi J. Geometry optimization of molecular structures in solution by the polarizable continuum model. J Comput Chem. 1998;19(4):404\u201317 Available from: isi:000072132200003.","journal-title":"J Comput Chem"},{"key":"5223_CR16","doi-asserted-by":"crossref","unstructured":"Ojo KK, Reid MC, Siddaramaiah LK, M\u00fcller J, Winzer P, Zhang Z, et al. Neospora caninum calcium-dependent protein kinase 1 is an effective drug target for neosporosis therapy. PLoS One. 2014;9(3):e92929.","DOI":"10.1371\/journal.pone.0092929"},{"issue":"SUPPL. 1","key":"5223_CR17","first-page":"553","volume":"36","author":"B Gajria","year":"2008","unstructured":"Gajria B, Bahl A, Brestelli J, Dommer J, Fischer S, Gao X, et al. ToxoDB: an integrated toxoplasma gondii database resource. Nucleic Acids Res. 2008;36(SUPPL. 1):553\u20136.","journal-title":"Nucleic Acids Res"},{"issue":"4","key":"5223_CR18","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/j.jmb.2009.06.053","volume":"392","author":"JP Kallio","year":"2009","unstructured":"Kallio JP, Auer S, J\u00e4nis J, Andberg M, Kruus K, Rouvinen J, et al. Structure-function studies of a Melanocarpus albomyces laccase suggest a pathway for oxidation of phenolic compounds. J Mol Biol. 2009;392(4):895\u2013909. https:\/\/doi.org\/10.1016\/j.jmb.2009.06.053 .","journal-title":"J Mol Biol"},{"key":"5223_CR19","doi-asserted-by":"crossref","unstructured":"Montazeri M, Sharif M, Sarvi S, Mehrzadi S, Ahmadpour E, Daryani A. A systematic review of in vitro and in vivo activities of anti-toxoplasma drugs and compounds (2006\u20132016). Front Microbiol. 2017;8:25.(JAN).","DOI":"10.3389\/fmicb.2017.00025"},{"issue":"16","key":"5223_CR20","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1038\/onc.2014.155","volume":"34","author":"Y Aye","year":"2014","unstructured":"Aye Y, Li M, Long MJC, Weiss RS. Ribonucleotide reductase and cancer: biological mechanisms and targeted therapies. Oncogene. 2014;34(16):2011\u201321.","journal-title":"Oncogene"},{"issue":"8","key":"5223_CR21","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1107\/S1744309112027108","volume":"68","author":"LJ Parker","year":"2012","unstructured":"Parker LJ, Watanabe H, Tsuganezawa K, Tomabechi Y, Handa N, Shirouzu M, et al. Flexibility of the P-loop of Pim-1 kinase: observation of a novel conformation induced by interaction with an inhibitor. Acta Crystallogr Sect F Struct Biol Cryst Commun. 2012;68(8):860\u20136.","journal-title":"Acta Crystallogr Sect F Struct Biol Cryst Commun"},{"key":"5223_CR22","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.bioorg.2017.10.014","volume":"75","author":"S Kaur Manjal","year":"2017","unstructured":"Kaur Manjal S, Kaur R, Bhatia R, Kumar K, Singh V, Shankar R, et al. Synthetic and medicinal perspective of thiazolidinones: a review. Bioorg Chem. 2017;75:406\u201323. https:\/\/doi.org\/10.1016\/j.bioorg.2017.10.014 .","journal-title":"Bioorg Chem"},{"issue":"1","key":"5223_CR23","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.ijpara.2011.11.007","volume":"42","author":"DC Lim","year":"2012","unstructured":"Lim DC, Cooke BM, Doerig C, Saeij JPJ. Toxoplasma and Plasmodium protein kinases: roles in invasion and host cell remodelling. Int J Parasitol. 2012;42(1):21\u201332. https:\/\/doi.org\/10.1016\/j.ijpara.2011.11.007 .","journal-title":"Int J Parasitol"},{"issue":"48","key":"5223_CR24","doi-asserted-by":"publisher","first-page":"34968","DOI":"10.1074\/jbc.M113.523266","volume":"288","author":"D Lim","year":"2013","unstructured":"Lim D, Gold DA, Julien L, Rosowski EE, Niedelman W, Yaffe MB, et al. Structure of the toxoplasma gondii ROP18 kinase domain reveals a second ligand binding pocket required for acute virulence. J Biol Chem. 2013;288(48):34968\u201380.","journal-title":"J Biol Chem"},{"issue":"5","key":"5223_CR25","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1038\/nsmb.1795","volume":"17","author":"AK Wernimont","year":"2010","unstructured":"Wernimont AK, Artz JD, Finerty P, Lin YH, Amani M, Allali-Hassani A, et al. Structures of apicomplexan calcium-dependent protein kinases reveal mechanism of activation by calcium. Nat Struct Mol Biol. 2010;17(5):596\u2013601. https:\/\/doi.org\/10.1038\/nsmb.1795 .","journal-title":"Nat Struct Mol Biol"},{"issue":"6","key":"5223_CR26","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1016\/j.chom.2009.05.017","volume":"5","author":"O Billker","year":"2009","unstructured":"Billker O, Lourido S, Sibley LD. Calcium-dependent signaling and kinases in apicomplexan parasites. Cell Host Microbe. 2009;5(6):612\u201322. https:\/\/doi.org\/10.1016\/j.chom.2009.05.017 .","journal-title":"Cell Host Microbe"},{"issue":"6","key":"5223_CR27","doi-asserted-by":"publisher","first-page":"2803","DOI":"10.1021\/jm201725v","volume":"55","author":"ET Larson","year":"2012","unstructured":"Larson ET, Ojo KK, Murphy RC, Johnson SM, Zhang Z, Kim JE, et al. Multiple determinants for selective inhibition of apicomplexan calcium-dependent protein kinase CDPK1. J Med Chem. 2012;55(6):2803\u201310.","journal-title":"J Med Chem"},{"issue":"13","key":"5223_CR28","doi-asserted-by":"publisher","first-page":"3381","DOI":"10.1093\/nar\/gkg520","volume":"31","author":"T Schwede","year":"2003","unstructured":"Schwede T, Kopp J, Guex N, Peitsch MC. SWISS-MODEL: an automated protein homology-modeling server. Nucleic Acids Res. 2003;31(13):3381\u20135.","journal-title":"Nucleic Acids Res"},{"issue":"13","key":"5223_CR29","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1002\/jcc.20084","volume":"25","author":"EF Pettersen","year":"2004","unstructured":"Pettersen EF, Goddard TD, Huang CC, Couch GS, Greenblatt DM, Meng EC, et al. UCSF chimera - a visualization system for exploratory research and analysis. J Comput Chem. 2004;25(13):1605\u201312.","journal-title":"J Comput Chem"},{"issue":"SUPPL. 2","key":"5223_CR30","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1093\/nar\/gki414","volume":"33","author":"RA Laskowski","year":"2005","unstructured":"Laskowski RA, Watson JD, Thornton JM. ProFunc: a server for predicting protein function from 3D structure. Nucleic Acids Res. 2005;33(SUPPL. 2):89\u201393.","journal-title":"Nucleic Acids Res"},{"issue":"16","key":"5223_CR31","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.1002\/jcc.21256","volume":"30","author":"G Morris","year":"2009","unstructured":"Morris G, Huey R, Lindstrom W, Sanner M, Belew R, Goodsell D, et al. AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility. J Comput Chem. 2009;30(16):2785\u201391.","journal-title":"J Comput Chem"},{"issue":"2","key":"5223_CR32","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","volume":"31","author":"O Trott","year":"2009","unstructured":"Trott O, Olson AJ. AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem. 2009;31(2):455\u201361.","journal-title":"J Comput Chem"},{"issue":"August","key":"5223_CR33","doi-asserted-by":"publisher","first-page":"2731","DOI":"10.1021\/ci200274q","volume":"51","author":"G Neudert","year":"2011","unstructured":"Neudert G, Klebe G. DSX: a knowledge-based scoring function for the assessment of receptor-ligand complexes. J Chem Inf Model. 2011;51(August):2731\u201345 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21863864 .","journal-title":"J Chem Inf Model"},{"issue":"3","key":"5223_CR34","doi-asserted-by":"publisher","first-page":"2287","DOI":"10.1021\/jm0203783","volume":"46","author":"R Wang","year":"2003","unstructured":"Wang R, Lu Y, Wang S. Comparative evaluation of 11 scoring functions for molecular docking. J Med Chem. 2003;46(3):2287\u2013303.","journal-title":"J Med Chem"},{"key":"5223_CR35","unstructured":"Dassault Syst\u00e8mes BIOVIA, Discovery Studio 2016, v16.1.0.15350. San Diego: Dassault Syst\u00e8mes; 2018. http:\/\/www.3dsbiovia.com\/about\/citations-references\/ ."},{"issue":"9","key":"5223_CR36","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1002\/jcc.10262","volume":"24","author":"KL Meagher","year":"2003","unstructured":"Meagher KL, Redman LT, Carlson HA. Development of polyphosphate parameters for use with the AMBER force field. J Comput Chem. 2003;24(9):1016\u201325.","journal-title":"J Comput Chem"},{"issue":"4","key":"5223_CR37","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1021\/acs.jcim.5b00674","volume":"56","author":"P Li","year":"2016","unstructured":"Li P, Merz KM. MCPB.py: a Python based metal center parameter builder. J Chem Inf Model. 2016;56(4):599\u2013604.","journal-title":"J Chem Inf Model"},{"key":"5223_CR38","volume-title":"AMBER 2016","author":"D Case","year":"2016","unstructured":"Case D, Betz R, Cerutti D, Cheatham T, III T, Darden R, et al. AMBER 2016. San Francisco: University of California; 2016."},{"issue":"1","key":"5223_CR39","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/0263-7855(96)00018-5","volume":"14","author":"W Humphrey","year":"1996","unstructured":"Humphrey W, Dalke A, Schulten K. VMD: Visual Molecular Dynamics. J Mol Graph [Internet]. 1996;14(1):33\u20138 Available from: http:\/\/www.sciencedirect.com\/science\/article\/pii\/0263785596000185 .","journal-title":"J Mol Graph [Internet]"},{"issue":"19","key":"5223_CR40","doi-asserted-by":"publisher","first-page":"3924","DOI":"10.1111\/j.1742-4658.2010.07793.x","volume":"277","author":"G Kozlov","year":"2010","unstructured":"Kozlov G, M\u00e4\u00e4tt\u00e4nen P, Thomas DY, Gehring K. A structural overview of the PDI family of proteins. FEBS J. 2010;277(19):3924\u201336.","journal-title":"FEBS J"},{"issue":"5806","key":"5223_CR41","doi-asserted-by":"publisher","first-page":"1780","DOI":"10.1126\/science.1133690","volume":"314","author":"JPJ Saeij","year":"2006","unstructured":"Saeij JPJ, Boyle JP, Coller S, Taylor S, Sibley LD, Brooke-Powell ET, et al. Polymorphic secreted kinases are key virulence factors in toxoplasmosis. Science (80- ). 2006;314(5806):1780\u20133.","journal-title":"Science (80- )"},{"issue":"18","key":"5223_CR42","doi-asserted-by":"publisher","first-page":"12578","DOI":"10.1074\/jbc.M113.544718","volume":"289","author":"J Du","year":"2014","unstructured":"Du J, An R, Chen L, Shen Y, Chen Y, Cheng L, et al. Toxoplasma gondii virulence factor rop18 inhibits the host nf-kb pathway by promoting p65 degradation. J Biol Chem. 2014;289(18):12578\u201392.","journal-title":"J Biol Chem"},{"issue":"2","key":"5223_CR43","doi-asserted-by":"publisher","first-page":"0200","DOI":"10.1371\/journal.ppat.0030014","volume":"3","author":"H El Hajj","year":"2007","unstructured":"El Hajj H, Lebrun M, Arold ST, Vial H, Labesse G, Dubremetz JF. ROP18 is a rhoptry kinase controlling the intracellular proliferation of toxoplasma gondii. PLoS Pathog. 2007;3(2):0200\u201311.","journal-title":"PLoS Pathog"},{"issue":"2","key":"5223_CR44","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1111\/cmi.12499","volume":"18","author":"T Hermanns","year":"2016","unstructured":"Hermanns T, M\u00fcller UB, K\u00f6nen-Waisman S, Howard JC, Steinfeldt T. The toxoplasma gondii rhoptry protein ROP18 is an Irga6-specific kinase and regulated by the dense granule protein GRA7. Cell Microbiol. 2016;18(2):244\u201359.","journal-title":"Cell Microbiol"},{"key":"5223_CR45","doi-asserted-by":"crossref","unstructured":"Xia J, Kong L, Zhou LJ, Wu SZ, Yao LJ, He C, et al. Genome-Wide bimolecular fluorescence complementation-based proteomic analysis of Toxoplasma gondii ROP18\u2019s human interactome shows its key role in regulation of cell immunity and apoptosis. Front Immunol. 2018;9:61(FEB).","DOI":"10.3389\/fimmu.2018.00061"},{"issue":"23","key":"5223_CR46","doi-asserted-by":"publisher","first-page":"E5344","DOI":"10.1073\/pnas.1801118115","volume":"115","author":"R An","year":"2018","unstructured":"An R, Tang Y, Chen L, Cai H, Lai D-H, Liu K, et al. Encephalitis is mediated by ROP18 of Toxoplasma gondii , a severe pathogen in AIDS patients. Proc Natl Acad Sci. 2018;115(23):E5344\u201352 Available from: http:\/\/www.pnas.org\/lookup\/doi\/10.1073\/pnas.1801118115 .","journal-title":"Proc Natl Acad Sci"},{"issue":"1","key":"5223_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13071-016-1943-1","volume":"10","author":"X Zhang","year":"2017","unstructured":"Zhang X, Su R, Cheng Z, Zhu W, Li Y, Wang Y, et al. A mechanistic study of toxoplasma gondii ROP18 inhibiting differentiation of C17.2 neural stem cells. Parasit Vectors. 2017;10(1):1\u201310.","journal-title":"Parasit Vectors"},{"issue":"2","key":"5223_CR48","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.parint.2013.10.012","volume":"63","author":"V S\u00e1nchez","year":"2014","unstructured":"S\u00e1nchez V, De-la-Torre A, G\u00f3mez-Mar\u00edn JE. Characterization of ROP18 alleles in human toxoplasmosis. Parasitol Int. 2014;63(2):463\u20139. https:\/\/doi.org\/10.1016\/j.parint.2013.10.012 .","journal-title":"Parasitol Int"},{"issue":"5","key":"5223_CR49","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s00430-014-0339-0","volume":"203","author":"E Torres-Morales","year":"2014","unstructured":"Torres-Morales E, Taborda L, Cardona N, De-la-Torre A, Sepulveda-Arias JC, Patarroyo MA, et al. Th1 and Th2 immune response to P30 and ROP18 peptides in human toxoplasmosis. Med Microbiol Immunol. 2014;203(5):315\u201322.","journal-title":"Med Microbiol Immunol"},{"issue":"1","key":"5223_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12859-015-0599-8","volume":"16","author":"AF Arenas","year":"2015","unstructured":"Arenas AF, Salcedo GE, Montoya AM, Gomez-Marin JE. MSCA: a spectral comparison algorithm between time series to identify protein-protein interactions. BMC Bioinformatics. 2015;16(1):1\u20139.","journal-title":"BMC Bioinformatics"},{"key":"5223_CR51","doi-asserted-by":"crossref","unstructured":"Arenas AF, Salcedo GE, Gomez-Marin JE. R script approach to infer toxoplasma infection mechanisms from microarrays and domain-domain protein interactions. Bioinform Biol Insights. 2017;11:1177932217747256.","DOI":"10.1177\/1177932217747256"},{"issue":"16","key":"5223_CR52","doi-asserted-by":"publisher","first-page":"4805","DOI":"10.1021\/jm060522a","volume":"49","author":"PD Lyne","year":"2006","unstructured":"Lyne PD, Lamb ML, Saeh JC. Accurate prediction of the relative potencies of members of a series of kinase inhibitors using molecular docking and MM-GBSA scoring. J Med Chem. 2006;49(16):4805\u20138.","journal-title":"J Med Chem"},{"issue":"28","key":"5223_CR53","doi-asserted-by":"publisher","first-page":"8408","DOI":"10.1021\/jp404160y","volume":"117","author":"L Xu","year":"2013","unstructured":"Xu L, Sun H, Li Y, Wang J, Hou T. Assessing the performance of MM\/PBSA and MM\/GBSA methods. 3. The impact of force fields and ligand charge models. J Phys Chem B. 2013;117(28):8408\u201321.","journal-title":"J Phys Chem B"},{"issue":"31","key":"5223_CR54","doi-asserted-by":"publisher","first-page":"16719","DOI":"10.1039\/C4CP01388C","volume":"16","author":"H Sun","year":"2014","unstructured":"Sun H, Li Y, Tian S, Xu L, Hou T. Assessing the performance of MM\/PBSA and MM\/GBSA methods. 4. Accuracies of MM\/PBSA and MM\/GBSA methodologies evaluated by various simulation protocols using PDBbind data set. Phys Chem Chem Phys. 2014;16(31):16719\u201329.","journal-title":"Phys Chem Chem Phys"},{"issue":"4","key":"5223_CR55","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/S0022-2836(03)00610-7","volume":"330","author":"H Gohlke","year":"2003","unstructured":"Gohlke H, Kiel C, Case DA. Insights into protein-protein binding by binding free energy calculation and free energy decomposition for the Ras-Raf and Ras-RalGDS complexes. J Mol Biol. 2003;330(4):891\u2013913.","journal-title":"J Mol Biol"},{"issue":"7","key":"5223_CR56","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1002\/jcc.23811","volume":"36","author":"G Pierdominici-Sottile","year":"2015","unstructured":"Pierdominici-Sottile G, Palma J. New insights into the meaning and usefulness of principal component analysis of concatenated trajectories. J Comput Chem. 2015;36(7):424\u201332.","journal-title":"J Comput Chem"},{"issue":"2","key":"5223_CR57","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1002\/(SICI)1097-0134(19980201)30:2<144::AID-PROT4>3.0.CO;2-N","volume":"30","author":"S Hayward","year":"1998","unstructured":"Hayward S, Berendsen HJC. Systematic analysis of domain motions in proteins from conformational change: new results on citrate synthase and T4 lysozyme. Proteins Struct Funct Genet. 1998;30(2):144\u201354.","journal-title":"Proteins Struct Funct Genet"},{"issue":"8","key":"5223_CR58","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1080\/17460441.2016.1195945","volume":"11","author":"J M\u00fcller","year":"2016","unstructured":"M\u00fcller J, Hemphill A. Drug target identification in protozoan parasites. Expert Opin Drug Discov. 2016;11(8):815\u201324.","journal-title":"Expert Opin Drug Discov"},{"issue":"SUPPL. 2","key":"5223_CR59","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1093\/nar\/gkp322","volume":"37","author":"P Benkert","year":"2009","unstructured":"Benkert P, K\u00fcnzli M, Schwede T. QMEAN server for protein model quality estimation. Nucleic Acids Res. 2009;37(SUPPL. 2):510\u20134.","journal-title":"Nucleic Acids Res"},{"key":"5223_CR60","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1472-6807-5-14","volume":"5","author":"BK Ho","year":"2005","unstructured":"Ho BK, Brasseur R. The Ramachandran plots of glycine and pre-proline. BMC Struct Biol. 2005;5:1\u201311.","journal-title":"BMC Struct Biol"},{"key":"5223_CR61","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.ejmech.2017.05.023","volume":"136","author":"JF de Oliveira","year":"2017","unstructured":"de Oliveira JF, Lima TS, Vendramini-Costa DB, de Lacerda Pedrosa SCB, Lafayette EA, da Silva RMF, et al. Thiosemicarbazones and 4-thiazolidinones indole-based derivatives: Synthesis, evaluation of antiproliferative activity, cell death mechanisms and topoisomerase inhibition assay [Internet]. Eur J Med Chem. 2017;136:305\u201314. https:\/\/doi.org\/10.1016\/j.ejmech.2017.05.023 Elsevier Masson SAS.","journal-title":"Eur J Med Chem"},{"key":"5223_CR62","doi-asserted-by":"crossref","unstructured":"Rocha-Roa C, Molina D, Cardona N. A perspective on thiazolidinone scaffold development as a new therapeutic strategy for toxoplasmosis. Front Cell Infect Microbiol. 2018;8.","DOI":"10.3389\/fcimb.2018.00360"},{"issue":"1","key":"5223_CR63","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1124\/pr.112.007336","volume":"66","author":"G Sliwoski","year":"2013","unstructured":"Sliwoski G, Kothiwale S, Meiler J, Lowe EW. Computational methods in drug discovery. Pharmacol Rev. 2013;66(1):334\u201395.","journal-title":"Pharmacol Rev"},{"issue":"1","key":"5223_CR64","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s12551-013-0130-2","volume":"6","author":"IA Guedes","year":"2014","unstructured":"Guedes IA, de Magalh\u00e3es CS, Dardenne LE. Receptor-ligand molecular docking. Biophys Rev. 2014;6(1):75\u201387.","journal-title":"Biophys Rev"},{"issue":"3","key":"5223_CR65","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1021\/acsinfecdis.5b00102","volume":"2","author":"C Simpson","year":"2016","unstructured":"Simpson C, Jones NG, Hull-Ryde EA, Kireev D, Stashko M, Tang K, et al. Identification of small molecule inhibitors that block the toxoplasma gondii Rhoptry kinase ROP18. ACS Infect Dis. 2016;2(3):194\u2013206.","journal-title":"ACS Infect Dis"},{"key":"5223_CR66","doi-asserted-by":"crossref","unstructured":"Niedelman W, Gold DA, Rosowski EE, Sprokholt JK, Lim D, Arenas AF, et al. The rhoptry proteins ROP18 and ROP5 mediate Toxoplasma gondii evasion of the murine, but not the human, interferon-gamma response. PLoS Pathog. 2012;8(6):e1002784.","DOI":"10.1371\/journal.ppat.1002784"},{"issue":"7","key":"5223_CR67","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1038\/emboj.2009.24","volume":"28","author":"W Qiu","year":"2009","unstructured":"Qiu W, Wernimont A, Tang K, Taylor S, Lunin V, Schapira M, et al. Novel structural and regulatory features of rhoptry secretory kinases in toxoplasma gondii. EMBO J. 2009;28(7):969\u201379. https:\/\/doi.org\/10.1038\/emboj.2009.24 .","journal-title":"EMBO J"},{"issue":"July","key":"5223_CR68","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.archoralbio.2018.07.015","volume":"95","author":"C Rocha-Roa","year":"2018","unstructured":"Rocha-Roa C, Cossio-P\u00e9rez R, Molina D, Pati\u00f1o J, Cardona N. In silico study of moxifloxacin derivatives with possible antibacterial activity against a resistant form of DNA gyrase from Porphyromonas gingivalis. Arch Oral Biol. 2018;95(July):30\u20139. https:\/\/doi.org\/10.1016\/j.archoralbio.2018.07.015 .","journal-title":"Arch Oral Biol"},{"issue":"12","key":"5223_CR69","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1517\/17460440802579975","volume":"3","author":"A Backes","year":"2008","unstructured":"Backes A, Zech B, Felber B, Klebl B, M\u00fcller G. Small-molecule inhibitors binding to protein kinases. Part I: exceptions from the traditional pharmacophore approach of type I inhibition. Expert Opin Drug Discov. 2008;3(12):1409\u201325 Available from: http:\/\/www.tandfonline.com\/doi\/full\/10.1517\/17460440802579975 .","journal-title":"Expert Opin Drug Discov"},{"issue":"12","key":"5223_CR70","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1517\/17460440802580106","volume":"3","author":"A Backes","year":"2008","unstructured":"Backes A, Zech B, Felber B, Klebl B, M\u00fcller G. Small-molecule inhibitors binding to protein kinase. Part II: the novel pharmacophore approach of type II and type III inhibition. Expert Opin Drug Discov. 2008;3(12):1427\u201349 Available from: http:\/\/www.tandfonline.com\/doi\/full\/10.1517\/17460440802580106 .","journal-title":"Expert Opin Drug Discov"},{"issue":"2","key":"5223_CR71","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.tibs.2010.09.006","volume":"36","author":"SS Taylor","year":"2011","unstructured":"Taylor SS, Kornev AP. Protein kinases: evolution of dynamic regulatory proteins. Trends Biochem Sci. 2011;36(2):65\u201377. https:\/\/doi.org\/10.1016\/j.tibs.2010.09.006 .","journal-title":"Trends Biochem Sci"}],"container-title":["BMC Genomics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12864-018-5223-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12864-018-5223-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12864-018-5223-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,12]],"date-time":"2024-07-12T21:59:48Z","timestamp":1720821588000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgenomics.biomedcentral.com\/articles\/10.1186\/s12864-018-5223-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,29]]},"references-count":71,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["5223"],"URL":"https:\/\/doi.org\/10.1186\/s12864-018-5223-7","relation":{},"ISSN":["1471-2164"],"issn-type":[{"value":"1471-2164","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,29]]},"assertion":[{"value":"10 June 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"856"}}